Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway.
Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Pharmacoepidemiol Drug Saf. 2024 Feb;33(2):e5763. doi: 10.1002/pds.5763.
Opioid analgesics (OA) and other pharmaceuticals have been associated with drug-induced deaths. However, there is a lack of knowledge regarding patterns of use of these pharmaceuticals in the population and regarding such associations. We identify and describe subgroups of people with different patterns of filled prescriptions of OA and other relevant pharmaceuticals and examine associations with drug-induced deaths. In addition, we estimate the proportion of drug-induced deaths with a filled OA prescription and OA as cause of death.
A Norwegian population-based nested case-control register study with cases (drug-induced deaths 2010-2018, N = 2388) and population controls matched for age, gender and year of inclusion (N = 21 465). Patterns of filled prescriptions for opioid analgesics (OA), benzodiazepines and benzodiazepine-related drugs, gabapentinoids, ADHD medication and antidepressants/antipsychotics were explored by k-means cluster analysis. Associations with drug-induced deaths were estimated by conditional logistic regression adjusted for sociodemographic characteristics. Overlap of filled OA prescriptions and OA as cause of death was estimated.
Five clusters were identified: 'few prescriptions', 'weak OA', 'ADHD medication', 'sedative/psychiatric morbidity' and 'strong OA'. The 'strong OA' cluster had higher socioeconomic status compared to the other groupings. The risk of drug-induced death was also highest in this cluster (OR = 35.5; CI 25.6-49.3) and, for 68% (CI 64-73) of cases, filled prescriptions for OA was indicated as the underlying cause of death.
The cluster analysis identified a subgroup with filled prescriptions of OA and other pharmaceuticals and a higher socioeconomic status than other subgroups. This subgroup had a high risk of drug-induced death that needs to be addressed.
阿片类镇痛药(OA)和其他药物已被认为与药物引起的死亡有关。然而,对于这些药物在人群中的使用模式以及此类关联,人们知之甚少。我们确定并描述了具有不同 OA 处方和其他相关药物填充模式的人群亚组,并研究了这些亚组与药物引起的死亡之间的关联。此外,我们还估计了有 OA 处方和 OA 作为死因的药物引起的死亡比例。
这是一项基于挪威人群的嵌套病例对照登记研究,病例组(2010-2018 年药物引起的死亡,N=2388)和年龄、性别和纳入年份相匹配的人群对照组(N=21465)。采用 k-均值聚类分析方法探讨了阿片类镇痛药(OA)、苯二氮䓬类和苯二氮䓬类相关药物、加巴喷丁类、ADHD 药物和抗抑郁药/抗精神病药的处方填充模式。采用条件逻辑回归模型,调整社会人口统计学特征后,估计了与药物引起的死亡之间的关联。估计了 OA 处方的重叠和 OA 作为死因的情况。
共确定了 5 个聚类:“处方少”、“弱 OA”、“ADHD 药物”、“镇静/精神疾病”和“强 OA”。与其他分组相比,“强 OA”聚类的社会经济地位较高。该聚类的药物引起的死亡风险也最高(OR=35.5;95%CI 25.6-49.3),并且对于 68%(95%CI 64-73)的病例,OA 处方是死亡的根本原因。
聚类分析确定了一个具有 OA 和其他药物处方的亚组,该亚组的社会经济地位高于其他亚组。这个亚组的药物引起的死亡风险较高,需要加以解决。